Neogen Newsroom

William Blair Maintains Neogen(NEOG.US) With Buy Rating

Moomoo NewsApr 25 01:33 ET

Neogen's Promising Outlook: Buy Rating Backed by Operational Strength and Attractive Valuation

TipRanksApr 24 05:49 ET

Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Cuts Target Price to $5

Moomoo NewsApr 23 01:35 ET

Neogen Is Maintained at Neutral by Piper Sandler

Dow JonesApr 22 12:22 ET

Neogen Price Target Cut to $5.00/Share From $6.40 by Piper Sandler

Dow JonesApr 22 12:22 ET

Neogen Analyst Ratings

BenzingaApr 22 12:11 ET

Analysts Conflicted on These Healthcare Names: Verona Pharma (VRNA), Neogen (NEOG) and ANI Pharmaceuticals (ANIP)

TipRanksApr 22 07:05 ET

William Blair Maintains Neogen(NEOG.US) With Buy Rating

Moomoo NewsApr 22 02:38 ET

Analysts Offer Insights on Healthcare Companies: Neogen (NEOG) and UniQure (QURE)

TipRanksApr 21 12:34 ET

William Blair Maintains Neogen(NEOG.US) With Buy Rating

Moomoo NewsApr 15 01:34 ET

Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Cuts Target Price to $6.4

Moomoo NewsApr 15 01:34 ET

Neogen Is Maintained at Neutral by Piper Sandler

Dow JonesApr 14 07:24 ET

Neogen Analyst Ratings

BenzingaApr 14 07:15 ET

Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Cuts Target Price to $13

Moomoo NewsApr 11 01:32 ET

Neogen Is Maintained at Buy by Guggenheim

Dow JonesApr 10 09:11 ET

Neogen Analyst Ratings

BenzingaApr 10 09:02 ET

Guggenheim Maintains Buy on Neogen, Lowers Price Target to $13

BenzingaApr 10 09:02 ET

William Blair Initiates Neogen(NEOG.US) With Buy Rating

Moomoo NewsApr 9 09:31 ET

Neogen (NEOG) Gets a Buy From William Blair

TipRanksApr 9 08:31 ET

Neogen Price Target Cut to $13.00/Share From $16.50 by Piper Sandler

Dow JonesJan 21 12:50 ET